Schwartz-Jampel Syndrome, Type 1
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
The results of the present study suggested that the compound heterozygous mutations in HSPG2 may be responsible the induction of SJS1, and demonstrated the genotype‑phenotype associations between mutations in the HSPG2 gene and clinical characteristics of SJS1.
|
29901129 |
2018 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
Identification of a novel splice site HSPG2 mutation and prenatal diagnosis in Schwartz Jampel Syndrome type 1 using whole exome sequencing.
|
27521129 |
2016 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
MGD |
A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking.
|
22449950 |
2012 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
MGD |
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
|
18647752 |
2008 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
MGD |
Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
|
17213231 |
2007 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
MGD |
Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.
|
11802174 |
2002 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
|
11279527 |
2001 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
CTD_human |
Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
|
11279527 |
2001 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
GeneticVariation
|
disease |
UNIPROT |
Here we describe mutations, including missense and splicing mutations, of the gene encoding perlecan (HSPG2) in three SJS1 families.
|
11101850 |
2000 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
Here we describe mutations, including missense and splicing mutations, of the gene encoding perlecan (HSPG2) in three SJS1 families.
|
11101850 |
2000 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we describe mutations, including missense and splicing mutations, of the gene encoding perlecan (HSPG2) in three SJS1 families.
|
11101850 |
2000 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
CTD_human |
Perlecan is essential for cartilage and cephalic development.
|
10545953 |
1999 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
MGD |
Perlecan is essential for cartilage and cephalic development.
|
10545953 |
1999 |
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Schwartz-Jampel Syndrome, Type 1
|
0.930 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|